Hung CC, et al. - In patients with hip osteoarthritis (OA), authors evaluated the correlation between use of anti-osteoporosis medications (AOMs) and risk of undergoing total hip arthroplasty (THA). Participants were patients diagnosed with hip OA, followed until THA, death of any cause, or December 31, 2013, whichever happened first. Findings suggested that there is no association between the use of AOMs and decreased risk of THA in patients with hip OA. Significant change was not demonstrated by the bisphosphonates or non-bisphosphonates users vs non-users in terms of risk of undergoing THA. They noted 75.62, 76.84, and 67.39 years to be the mean age of bisphosphonates users, non-bisphosphonates users, and non-users, respectively.